Trinity Biotech PLC
TRIB1.190USD
-0.020-1.65%
收盘 09/19, 16:00（美东）报价延迟15分钟
9.87M总市值
亏损市盈率 TTM
关于 Trinity Biotech PLC 公司
Trinity Biotech plc 是一家位于爱尔兰的商业阶段生物技术公司。该公司专注于人体诊断和糖尿病管理解决方案，包括可穿戴生物传感器。该公司开发、收购、制造和销售诊断系统，包括试剂和仪器，用于诊断市场的即时诊断和临床实验室部分，并已进入可穿戴生物传感器行业。该公司打算开发一系列生物传感器设备和相关服务，从连续血糖监测产品开始。其产品用于检测传染病和量化血清、血浆和全血中的糖化血红蛋白水平和其他化学参数。该公司还通过 EpiCapture Limited 开发了一种用于监测侵袭性前列腺癌风险的非侵入性测试。该公司在美国直接销售其产品，并通过国际分销商网络销售。
公司简介
公司代码TRIB
公司名称Trinity Biotech PLC
上市日期Oct 21, 1992
CEOMr. John Gillard
员工数量- -
证券类型Depository Receipt
年结日Oct 21
公司地址Ida Business Park, Bray, Co Wicklow
城市DUBLIN
上市交易所NASDAQ Global Select Consolidated
国家Ireland
邮编18
电话01135312955111
网址https://www.trinitybiotech.com/
公司代码TRIB
上市日期Oct 21, 1992
CEOMr. John Gillard
公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Susan O'Connor
Ms. Susan O'Connor
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Matthew Wictome
Dr. Matthew Wictome
Vice President - Quality and Regulatory Affairs
Vice President - Quality and Regulatory Affairs
--
--
Mr. Eric Ribner
Mr. Eric Ribner
Investors Relations
Investors Relations
--
--
Mr. Ronan O'caoimh
Mr. Ronan O'caoimh
Founder, Executive Director
Founder, Executive Director
--
--
Mr. John Gillard
Mr. John Gillard
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
--
--
Ms. Eibhlin Kelly
Ms. Eibhlin Kelly
Chief Information Officer
Chief Information Officer
--
--
Dr. Gary Keating, Ph.D.
Dr. Gary Keating, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Colm Molloy
Mr. Colm Molloy
Group Director of Human Resources and Culture
Group Director of Human Resources and Culture
--
--
Dr. James (Jim) Walsh, Ph.D.
Dr. James (Jim) Walsh, Ph.D.
Executive Director - Business Development
Executive Director - Business Development
--
--
Mr. Andrew Omidvar, Ph.D.
Mr. Andrew Omidvar, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Susan O'Connor
Ms. Susan O'Connor
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Matthew Wictome
Dr. Matthew Wictome
Vice President - Quality and Regulatory Affairs
Vice President - Quality and Regulatory Affairs
--
--
Mr. Eric Ribner
Mr. Eric Ribner
Investors Relations
Investors Relations
--
--
Mr. Ronan O'caoimh
Mr. Ronan O'caoimh
Founder, Executive Director
Founder, Executive Director
--
--
Mr. John Gillard
Mr. John Gillard
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
--
--
Ms. Eibhlin Kelly
Ms. Eibhlin Kelly
Chief Information Officer
Chief Information Officer
--
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Clinical Laboratory
42.29M
74.41%
Point of care
9.09M
16.00%
Laboratory services
5.45M
9.59%
地区USD
名称
营收
占比
Americas
44.98M
79.15%
Ireland
11.85M
20.85%
Eliminations
0.00
0.00%
业务
地区
业务USD
名称
营收
占比
Clinical Laboratory
42.29M
74.41%
Point of care
9.09M
16.00%
Laboratory services
5.45M
9.59%
股东统计
更新时间: 8月23日 周六
更新时间: 8月23日 周六
持股股东
股东类型
持股股东
持股股东
占比
MiCo IVD Holdings, LLC
2.40%
Perceptive Advisors LLC
1.92%
Hunter Associates Investment Management LLC
0.47%
Whitefort Capital Management, LP
0.09%
Renaissance Technologies LLC
0.06%
其他
95.06%
持股股东
持股股东
占比
MiCo IVD Holdings, LLC
2.40%
Perceptive Advisors LLC
1.92%
Hunter Associates Investment Management LLC
0.47%
Whitefort Capital Management, LP
0.09%
Renaissance Technologies LLC
0.06%
其他
95.06%
股东类型
持股股东
占比
Corporation
2.40%
Private Equity
1.92%
Investment Advisor
0.59%
Hedge Fund
0.17%
Investment Advisor/Hedge Fund
0.05%
Research Firm
0.03%
Venture Capital
0.03%
其他
94.81%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
50
3.17M
16.99%
-2.03M
2025Q1
53
3.13M
16.78%
-2.10M
2024Q4
50
4.89M
27.09%
-355.77K
2024Q3
47
4.97M
53.06%
-277.40K
2024Q2
45
4.94M
57.57%
-285.83K
2024Q1
44
5.20M
60.32%
-76.86K
2023Q4
40
3.94M
51.41%
+207.86K
2023Q3
42
3.97M
51.90%
+190.94K
2023Q2
47
3.98M
52.08%
+190.03K
2023Q1
47
3.51M
70.22%
+1.91M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
MiCo IVD Holdings, LLC
2.24M
12.01%
--
--
Dec 17, 2024
Hunter Associates Investment Management LLC
375.11K
2.01%
-3.48K
-0.92%
Mar 31, 2025
Whitefort Capital Management, LP
81.90K
0.44%
--
--
Mar 31, 2025
Renaissance Technologies LLC
76.67K
0.41%
-112.39K
-59.45%
Mar 31, 2025
Highbridge Capital Management, LLC
33.75K
0.18%
+33.75K
--
Mar 31, 2024
Moss Adams Wealth Advisors LLC
25.67K
0.14%
--
--
Mar 31, 2025
Raymond James & Associates, Inc.
25.35K
0.14%
--
--
Mar 31, 2025
Cambridge Investment Research Advisors, Inc.
22.28K
0.12%
--
--
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Feb 13, 2024
Merger
5→1
Feb 13, 2024
Merger
5→1
Feb 13, 2024
Merger
5→1
Feb 13, 2024
Merger
5→1
公告日期
类型
比率
Feb 13, 2024
Merger
5→1
Feb 13, 2024
Merger
5→1
Feb 13, 2024
Merger
5→1
Feb 13, 2024
Merger
5→1
